ArticleMedicine2025
Gamma knife radiosurgery for metastatic brain tumors with contrast media leakage: Case series.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleThe phenomenon of "contrast media leakage" in metastatic brain tumors, where contrast enhancement of perilesional edema can overestimate actual tumor volume. PATIENT CONCERNS AND DIAGNOSIS: The radiologic and pathologic characteristics of 3 surgically resected metastatic brain tumors with contrast media leakage were analyzed. Five metastatic tumors were treated with gamma knife radiosurgery (GKRS), deliberately avoiding areas of contrast media leakage.
interventionsThe characteristics of these tumors, the administered radiation dosage, and progression-free survival were evaluated. OUTCOMES: The region of "contrast media leakage within edema" showed different signals from tumor boundaries on T2-weighted magnetic resonance imaging, fluid-attenuated inversion recovery, and apparent diffusion coefficient maps. No increased cerebral blood volume and a low transfer coefficient were indicated on perfusion images. Pathologically, these areas showed prominent endothelial proliferation and perivascular lymphocyte infiltration without tumor cell infiltration. Immunohistochemical staining revealed a weak positive for clauidin-5 and a strong positive with antibodies against leukocyte common antigen and cluster of differentiation 68. Five lesions treated with GKRS were adenocarcinomas of lung origin. The median radiation volume was 3.10 cc (range, 2.32-3.78), and the median radiation dose was 22 Gy (range, 20-22). Treatment responses were nearly complete in 1, partial in 3, and stable in 1. There were recurrences at 6.0 and 10.0 months after GKRS. Median progression-free survival was 18.2 months (95% confidence interval: 9.2-27.1), and there was no treatment-related complication. LESSONS: This study revealed that the region of "contrast media leakage within edema" showed more pronounced blood-brain barrier disruption associated with inflammatory cells. It was effective when the GKRS targeted the actual tumor, excluding the area with contrast media leakage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.